APUS
Apimeds Pharmaceuticals US, Inc.
NYSE MKT: APUS · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.88
+0.00% today
Updated 2026-04-29
Market cap
$2.36M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.41
Dividend yield
—
52W range
$1 – $4
Volume
0.1M
Apimeds Pharmaceuticals US, Inc. (APUS) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
0.00%
ROA
-409.40%
Debt/equity
0.06x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2021 | $0.00 | $-1.03M | — | — | — |
| 2022 | $0.00 | $-668666.00 | — | — | — |
| 2023 | $0.00 | $-777694.00 | — | — | — |
| 2024 | $0.00 | $-1.39M | — | — | — |